358 related articles for article (PubMed ID: 23264997)
1. Generation of clinically relevant "induced pluripotent stem" (iPS) cells.
Heffernan C; Sumer H; Verma PJ
J Stem Cells; 2011; 6(3):109-27. PubMed ID: 23264997
[TBL] [Abstract][Full Text] [Related]
2. Pluripotent stem cells induced from adult neural stem cells by reprogramming with two factors.
Kim JB; Zaehres H; Wu G; Gentile L; Ko K; Sebastiano V; Araúzo-Bravo MJ; Ruau D; Han DW; Zenke M; Schöler HR
Nature; 2008 Jul; 454(7204):646-50. PubMed ID: 18594515
[TBL] [Abstract][Full Text] [Related]
3. Activation of pluripotency-associated genes in mouse embryonic fibroblasts by non-viral transfection with in vitro-derived mRNAs encoding Oct4, Sox2, Klf4 and cMyc.
Tavernier G; Wolfrum K; Demeester J; De Smedt SC; Adjaye J; Rejman J
Biomaterials; 2012 Jan; 33(2):412-7. PubMed ID: 21993235
[TBL] [Abstract][Full Text] [Related]
4. Adenoviral gene delivery can reprogram human fibroblasts to induced pluripotent stem cells.
Zhou W; Freed CR
Stem Cells; 2009 Nov; 27(11):2667-74. PubMed ID: 19697349
[TBL] [Abstract][Full Text] [Related]
5. Generation of human induced pluripotent stem cells from cord blood cells.
Nishishita N; Takenaka C; Fusaki N; Kawamata S
J Stem Cells; 2011; 6(3):101-8. PubMed ID: 23264996
[TBL] [Abstract][Full Text] [Related]
6. More synergetic cooperation of Yamanaka factors in induced pluripotent stem cells than in embryonic stem cells.
Huang J; Chen T; Liu X; Jiang J; Li J; Li D; Liu XS; Li W; Kang J; Pei G
Cell Res; 2009 Oct; 19(10):1127-38. PubMed ID: 19736564
[TBL] [Abstract][Full Text] [Related]
7. Overexpression Nanog activates pluripotent genes in porcine fetal fibroblasts and nuclear transfer embryos.
Zhang L; Luo YB; Bou G; Kong QR; Huan YJ; Zhu J; Wang JY; Li H; Wang F; Shi YQ; Wei YC; Liu ZH
Anat Rec (Hoboken); 2011 Nov; 294(11):1809-17. PubMed ID: 21972213
[TBL] [Abstract][Full Text] [Related]
8. Optimal reprogramming factor stoichiometry increases colony numbers and affects molecular characteristics of murine induced pluripotent stem cells.
Tiemann U; Sgodda M; Warlich E; Ballmaier M; Schöler HR; Schambach A; Cantz T
Cytometry A; 2011 Jun; 79(6):426-35. PubMed ID: 21548079
[TBL] [Abstract][Full Text] [Related]
9. Oct4 and klf4 reprogram dermal papilla cells into induced pluripotent stem cells.
Tsai SY; Clavel C; Kim S; Ang YS; Grisanti L; Lee DF; Kelley K; Rendl M
Stem Cells; 2010 Feb; 28(2):221-8. PubMed ID: 20014278
[TBL] [Abstract][Full Text] [Related]
10. [Induction and characterization of induced pluripotent stem (iPS) cells: a review].
Cheng D; Lei L; Lu Z; Li Z; Wang H
Sheng Wu Gong Cheng Xue Bao; 2010 Apr; 26(4):421-30. PubMed ID: 20575428
[TBL] [Abstract][Full Text] [Related]
11. Klf4 interacts directly with Oct4 and Sox2 to promote reprogramming.
Wei Z; Yang Y; Zhang P; Andrianakos R; Hasegawa K; Lyu J; Chen X; Bai G; Liu C; Pera M; Lu W
Stem Cells; 2009 Dec; 27(12):2969-78. PubMed ID: 19816951
[TBL] [Abstract][Full Text] [Related]
12. Emerging methods for preparing iPS cells.
Miyazaki S; Yamamoto H; Miyoshi N; Takahashi H; Suzuki Y; Haraguchi N; Ishii H; Doki Y; Mori M
Jpn J Clin Oncol; 2012 Sep; 42(9):773-9. PubMed ID: 22826352
[TBL] [Abstract][Full Text] [Related]
13. Induced pluripotent stem (iPS) cell research overview.
Liu SP; Fu RH; Huang YC; Chen SY; Chien YJ; Hsu CY; Tsai CH; Shyu WC; Lin SZ
Cell Transplant; 2011; 20(1):15-9. PubMed ID: 20887681
[TBL] [Abstract][Full Text] [Related]
14. Using small molecules to improve generation of induced pluripotent stem cells from somatic cells.
Desponts C; Ding S
Methods Mol Biol; 2010; 636():207-18. PubMed ID: 20336525
[TBL] [Abstract][Full Text] [Related]
15. Cell line-dependent differentiation of induced pluripotent stem cells into cardiomyocytes in mice.
Kaichi S; Hasegawa K; Takaya T; Yokoo N; Mima T; Kawamura T; Morimoto T; Ono K; Baba S; Doi H; Yamanaka S; Nakahata T; Heike T
Cardiovasc Res; 2010 Nov; 88(2):314-23. PubMed ID: 20547733
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo differentiation of induced pluripotent stem cells into male germ cells.
Cai H; Xia X; Wang L; Liu Y; He Z; Guo Q; Xu C
Biochem Biophys Res Commun; 2013 Apr; 433(3):286-91. PubMed ID: 23524261
[TBL] [Abstract][Full Text] [Related]
17. Induced pluripotent stem cells.
Zaehres H; Kim JB; Schöler HR
Methods Enzymol; 2010; 476():309-25. PubMed ID: 20691874
[TBL] [Abstract][Full Text] [Related]
18. The timing of retroviral silencing correlates with the quality of induced pluripotent stem cell lines.
Okada M; Yoneda Y
Biochim Biophys Acta; 2011 Feb; 1810(2):226-35. PubMed ID: 20965232
[TBL] [Abstract][Full Text] [Related]
19. Hypoxia and TP53 deficiency for induced pluripotent stem cell-like properties in gastrointestinal cancer.
Hoshino H; Nagano H; Haraguchi N; Nishikawa S; Tomokuni A; Kano Y; Fukusumi T; Saito T; Ozaki M; Sakai D; Satoh T; Eguchi H; Sekimoto M; Doki Y; Mori M; Ishii H
Int J Oncol; 2012 May; 40(5):1423-30. PubMed ID: 22293932
[TBL] [Abstract][Full Text] [Related]
20. NANOG is a key factor for induction of pluripotency in bovine adult fibroblasts.
Sumer H; Liu J; Malaver-Ortega LF; Lim ML; Khodadadi K; Verma PJ
J Anim Sci; 2011 Sep; 89(9):2708-16. PubMed ID: 21478453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
